Trial Profile
INdividualized ITI Based on Fviii(ATE) Protection by VWF (INITIATE)
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Factor VIII/von Willebrand factor (Primary)
- Indications Haemophilia A
- Focus Therapeutic Use
- Acronyms INITIATE
- 01 Jun 2020 According to Clinicaltrials.gov the trial was discontinued due to termination of funding from the sponsor.
- 14 May 2020 Status changed from recruiting to discontinued.
- 04 Dec 2018 Results presented at the 60th Annual Meeting and Exposition of the American Society of Hematology.